Christopher Gibson - 27 Aug 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
27 Aug 2024
Net transactions value
+$12,400
Form type
4
Filing time
27 Aug 2024, 16:10:34 UTC
Previous filing
26 Aug 2024
Next filing
28 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Options Exercise $12,400 +5,000 +0.67% $2.48 747,656 27 Aug 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -5,000 -1.7% $0.000000 297,500 27 Aug 2024 Class A Common Stock 5,000 $2.48 Direct F1
holding RXRX Class B Common Stock 6,176,700 27 Aug 2024 Class A Common Stock 0 $0.000000 Direct F2
holding RXRX Class B Common Stock 486,000 27 Aug 2024 Class A Common Stock 0 $0.000000 by LAHWRAN-3 LLC F2, F3
holding RXRX Class B Common Stock 388,000 27 Aug 2024 Class A Common Stock 0 $0.000000 by LAHWRAN-4 LLC F2, F4
holding RXRX Class B Common Stock 67,875 27 Aug 2024 Class A Common Stock 0 $0.000000 by Gibson Family Trust F2, F5
holding RXRX Stock Option (Right to Buy) 813,600 27 Aug 2024 Class A Common Stock 0 $8.55 Direct F6
holding RXRX Stock Option (Right to Buy) 399,002 27 Aug 2024 Class A Common Stock 0 $11.40 Direct F7
holding RXRX Stock Option (Right to Buy) 5,436 27 Aug 2024 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 666,898 27 Aug 2024 Class A Common Stock 0 $10.09 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F2 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F3 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F4 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F5 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
F6 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F7 The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F8 The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.